Search company, investor...

Predict your next investment

Longwood Fund company logo
Venture Capital
longwoodfund.com

Investments

61

Portfolio Exits

15

Funds

7

About Longwood Fund

Longwood Fund is a healthcare venture capital firm that founds, manages, and builds healthcare companies. Longwood's mission is to identify technologies and to found companies that will advance new therapeutics that can not only make a difference in the lives of patients worldwide, but also create significant value for investors. This is achieved by leveraging the management team's history of successful healthcare company formation and operational leadership.

Headquarters Location

800 Boylston Street Suite 1555

Boston, Massachusetts, 02199,

United States

617-351-2590

Want to inform investors similar to Longwood Fund about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Expert Collections containing Longwood Fund

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Longwood Fund in 1 Expert Collection, including Vitamin & Supplement Startups.

V

Vitamin & Supplement Startups

237 items

Latest Longwood Fund News

Phil Vickers talks new role as head of Longwood’s Solu after Faze shutdown; Regeneron CFO to retire in February

Sep 15, 2023

News Reporter Phil Vick­ers start­ed last week as pres­i­dent and CEO of Solu Ther­a­peu­tics, a Long­wood Fund start­up de­vel­op­ing small mol­e­cule-an­ti­body chimeras. He takes the place of Long­wood ex­ec­u­tive part­ner David Don­abe­di­an, who has tak­en the ear­ly CEO roles at a num­ber of com­pa­nies Long­wood has backed, in­clud­ing Ax­i­al Ther­a­peu­tics, Im­muneID and DEM Bio­Phar­ma. Vick­ers was pre­vi­ous­ly head of Faze Med­i­cines, a con­den­sates biotech start­ed by Third Rock that launched with $81 mil­lion in 2020 be­fore shut­ting down at the end of last year . Unlock this article instantly by becoming a free subscriber. You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news. SIGN UP

Longwood Fund Investments

61 Investments

Longwood Fund has made 61 investments. Their latest investment was in Solu Therapeutics as part of their Seed VC on August 8, 2023.

CBI Logo

Longwood Fund Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/1/2023

Seed VC

Solu Therapeutics

$31M

Yes

1

6/6/2023

Series A

AAVantgarde Bio

$65.1M

Yes

3

2/24/2023

Unattributed VC

CoLabs

$0.32M

Yes

2

12/6/2022

Series C - II

Subscribe to see more

$99M

Subscribe to see more

10

9/20/2022

Series A

Subscribe to see more

Subscribe to see more

10

Date

8/1/2023

6/6/2023

2/24/2023

12/6/2022

9/20/2022

Round

Seed VC

Series A

Unattributed VC

Series C - II

Series A

Company

Solu Therapeutics

AAVantgarde Bio

CoLabs

Subscribe to see more

Subscribe to see more

Amount

$31M

$65.1M

$0.32M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

3

2

10

10

Longwood Fund Portfolio Exits

15 Portfolio Exits

Longwood Fund has 15 portfolio exits. Their latest portfolio exit was Pyxis Oncology on October 08, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/8/2021

IPO

$99M

Public

9

7/16/2021

IPO

$99M

Public

4

4/30/2021

IPO

$99M

Public

5

6/22/2020

Acquired - II

Subscribe to see more

$99M

Subscribe to see more

10

5/23/2019

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/8/2021

7/16/2021

4/30/2021

6/22/2020

5/23/2019

Exit

IPO

IPO

IPO

Acquired - II

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Public

Public

Subscribe to see more

Subscribe to see more

Sources

9

4

5

10

10

Longwood Fund Fund History

7 Fund Histories

Longwood Fund has 7 funds, including Longwood Fund VI.

Closing Date

Fund

Fund Type

Status

Amount

Sources

5/5/2023

Longwood Fund VI

$180M

3

7/23/2020

Longwood Fund V

Subscribe to see more

Subscribe to see more

$99M

10

12/31/2016

Longwood Fund IV

Subscribe to see more

Subscribe to see more

10

12/31/2015

Longwood Fund III

Subscribe to see more

Subscribe to see more

10

5/15/2014

Longwood Fund II

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

5/5/2023

7/23/2020

12/31/2016

12/31/2015

5/15/2014

Fund

Longwood Fund VI

Longwood Fund V

Longwood Fund IV

Longwood Fund III

Longwood Fund II

Fund Type

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$180M

$99M

$99M

Sources

3

10

10

10

10

Longwood Fund Team

3 Team Members

Longwood Fund has 3 team members, including , .

Name

Work History

Title

Status

Rich Aldrich

Founder

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Rich Aldrich

Subscribe to see more

Subscribe to see more

Work History

Title

Founder

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.